Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality
about
Aortic Stenosis, a Left Ventricular Disease: Insights from Advanced ImagingPostinfarct Left Ventricular Remodelling: A Prevailing Cause of Heart FailureRisk Stratification in Patients With Aortic Stenosis Using Novel Imaging ApproachesMagnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologiesAtrial fibrillation: effects beyond the atrium?Myocardial Tissue Characterization: Histological and Pathophysiological CorrelationThe cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fractionHypothyroidism and its rapid correction alter cardiac remodelingClinical Utility and Future Applications of PET/CT and PET/CMR in Cardiology.Multiparametric CMR imaging of infarct remodeling in a percutaneous reperfused Yucatan mini-pig model.A computational model of cardiac fibroblast signaling predicts context-dependent drivers of myofibroblast differentiation.Noninvasive Cardiovascular Risk Assessment of the Asymptomatic Diabetic Patient: The Imaging Council of the American College of CardiologyComputational modeling of cardiac fibroblasts and fibrosisMyocardial Regional Interstitial Fibrosis is Associated With Left Intra-Ventricular Dyssynchrony in Patients With Heart Failure: A Cardiovascular Magnetic Resonance Study.Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis.Diffuse left ventricular interstitial fibrosis is associated with sub-clinical myocardial dysfunction in Alström Syndrome: an observational studyAdvances in parametric mapping with CMR imagingMyocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation.Effectiveness of late gadolinium enhancement to improve outcomes prediction in patients referred for cardiovascular magnetic resonance after echocardiography.Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications.T1-mapping in the heart: accuracy and precisionLeft ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR.Developing therapies for heart failure with preserved ejection fraction: current state and future directionsSubclinical Myocardial Disease in Heart Failure Detected by CMR.T1 measurements for detection of expansion of the myocardial extracellular volume in chronic obstructive pulmonary diseaseAccuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE.Associations of electrocardiographic P-wave characteristics with left atrial function, and diffuse left ventricular fibrosis defined by cardiac magnetic resonance: The PRIMERI StudyPotential reduction of interstitial myocardial fibrosis with renal denervation.Electrocardiographic deep terminal negativity of the P wave in V(1) and risk of sudden cardiac death: the Atherosclerosis Risk in Communities (ARIC) studyEvaluation of post-contrast myocardial t1 in duchenne muscular dystrophy using cardiac magnetic resonance imaging.Myocardial factor revisited: The importance of myocardial fibrosis in adults with congenital heart diseaseGadolinium free cardiovascular magnetic resonance with 2-point Cine balanced steady state free precession.T1 at 1.5T and 3T compared with conventional T2* at 1.5T for cardiac siderosis.Renal Denervation Findings on Cardiac and Renal Fibrosis in Rats with Isoproterenol Induced Cardiomyopathy.The protein binding substance ibuprofen does not affect the T1 time or partition coefficient in contrast-enhanced cardiovascular magnetic resonanceIncreased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophyEndocardial Remodeling in Heart Failure Patients with Impaired and Preserved Left Ventricular Systolic Function--A Magnetic Resonance Image StudyMyocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapyType 2 diabetes mellitus and exercise impairment
P2860
Q26744203-9FE6C9A4-5FBD-4AA3-89CF-0A605C695810Q26753845-2ED94355-D7BC-4432-85F7-3FCCFC837E19Q26801333-EBE01D02-2DEF-430D-BC5B-0E7DDAF42778Q26824231-A1C6F435-FFA0-4683-B7E0-E7BA48289025Q26864877-C134E3C8-C4EA-4AF8-9942-B50E4B971808Q26996570-7B290387-8D67-43F4-824D-36FC8D789A82Q27024279-3868FD1B-E100-44A6-9247-2798664635CDQ27339180-4F32EEDD-A1DF-4041-9617-808F70D044BFQ28073135-FBF50D1E-AF76-459E-8FED-B91503E595FFQ30274835-21EEB6B6-744E-47CE-8995-09510571E511Q30277087-C58F7484-8666-492E-A7E8-DC051D49BA24Q30277401-532028A8-AFA7-4A2C-8DB5-E46FD4777A7CQ30278019-8A46FB99-82E7-4335-995F-AF3ED2E809D9Q30391425-F1AE6D7B-C1CD-427E-9888-17FA4CD4DC98Q30407667-0AC4C276-B5B3-4D70-9937-AD0867B27754Q30408445-C09574EF-77FC-46F9-BB28-AA390C0A1F0EQ30412201-47EC2318-4E93-4906-993E-F49A7CF36CCFQ30421950-98CA0A95-33E7-4FC0-BEEB-AB228B116F8BQ30456092-C47E3F76-2BAF-4735-B75D-C34E194E789FQ30541197-A0FC2E5E-77AE-4200-A136-368538A1CEFDQ30725831-EB946E36-2D4A-499F-9086-31F03343163BQ30867239-19A03E08-DBA7-44B0-BD7C-F11FA7BA28D9Q33168755-726451EB-F9E2-4697-B5DF-385BC3A579D2Q33639223-45916A5B-861B-491D-AF1B-D2DB22724E8BQ34040150-975BD149-3490-4C28-8DEB-1427649AEF72Q34644430-145E003E-7B73-4287-BC16-BBC4907B23ADQ34681124-B51FE73B-FB89-4AB2-861E-8F3B314E0919Q34778823-A363CCA3-F751-429B-9121-45E0C227F394Q35115074-CEE5F783-FF2D-4D53-8CAB-F2035F5DB96AQ35115105-C5E7D724-78C5-4C04-AA53-806E9B4CECA3Q35629034-7C2976AA-BAC6-440C-8823-F2C289B9D5AAQ35655721-87BBB4BE-C72B-4B79-A1EB-984BC15D4D24Q36235217-8219645D-69A2-4939-B2A7-453C8D8CF0C8Q36318293-C0A50CB3-64E3-44D9-850C-17C96F604028Q36392895-2EC0AA62-4D1B-459D-9983-D82E4B5F39FBQ36406587-7212A1EA-E0AF-4BA7-BD66-AB4CEE5CE278Q36489696-DCCFF7D1-F577-461E-85FE-897F6E1DE3F7Q36579775-6C63DC0E-0FE9-4413-8A20-74E4D8BF3C6AQ36625503-6C55B165-B48E-401D-9905-414768918266Q36673620-D79346B0-E98E-4507-910E-D69CE5A18338
P2860
Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Association between extracellu ...... nance and short-term mortality
@ast
Association between extracellu ...... nance and short-term mortality
@en
type
label
Association between extracellu ...... nance and short-term mortality
@ast
Association between extracellu ...... nance and short-term mortality
@en
prefLabel
Association between extracellu ...... nance and short-term mortality
@ast
Association between extracellu ...... nance and short-term mortality
@en
P2093
P2860
P1433
P1476
Association between extracellu ...... nance and short-term mortality
@en
P2093
Ali A Aneizi
Amanda M Klock
Christopher G Meier
David S Schwartzman
Erik B Schelbert
Jonathan Shakesprere
Kayla Piehler
Marc A Simon
Sanjeev G Shroff
Stephen M Testa
P2860
P304
P356
10.1161/CIRCULATIONAHA.111.089409
P407
P577
2012-07-31T00:00:00Z